Patents by Inventor M. Scot Roberts

M. Scot Roberts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240277815
    Abstract: This disclosure relates to the once weekly dosing regimen of a dual GLP-1R and GCGR agonist, formulations, and methods of using the same for treatment of cardiovascular disease/disorder and/or reducing risk factors thereof by inducing reduction of pathogenic serum lipid mediators in a human being, wherein the human may or may not have other comorbidities such as obesity and/or type 2 diabetes. The dual GLP-1R and GCGR agonist includes the peptide product of SEQ ID NO. 1 (pemvidutide).
    Type: Application
    Filed: November 6, 2023
    Publication date: August 22, 2024
    Applicant: Spitfire Pharma LLC
    Inventors: John Joseph Suschak, III, Bertrand Victor Gilbert Georges, Sarah K. Browne, Matthew Scott Harris, M. Scot Roberts, Maynara Lucca Andrade
  • Publication number: 20240269238
    Abstract: This disclosure relates to the once weekly dosing regimen of a dual GLP-1R and GCGR agonist, formulations, and methods of using the same for inducing weight loss in a human being with fatty liver disease, wherein the human may or may not have other comorbidities such as type 2 diabetes and/or cardiovascular disease/disorder. The dual GLP-1R and GCGR agonist includes the peptide product of SEQ ID NO. 1 (pemvidutide).
    Type: Application
    Filed: September 14, 2023
    Publication date: August 15, 2024
    Applicant: Spitfire Pharma LLC
    Inventors: Sarah K. Browne, Matthew Scott Harris, John Joseph Suschak, III, Bertrand Victor Gilbert Georges, M. Scot Roberts
  • Publication number: 20240148879
    Abstract: This disclosure relates to the field of peptides, formulations, and methods of using the same, including but not limited to modified peptides derived from any of SEQ ID NOS. 1-29.
    Type: Application
    Filed: February 21, 2022
    Publication date: May 9, 2024
    Inventors: M. Scot Roberts, Bertrand Victor Gilbert Georges
  • Publication number: 20220354943
    Abstract: Disclosed herein are methods for generating a protective immunogenic response via intranasal administration of an immunogenic composition (e.g., vaccine)/therapeutic immunogenic composition in a mammalian subject. Certain dosing positions of the subject during the administration of immunogenic agents, such that nostrils are tilted upwards, while in a modified sitting, reclining and/or supine posture, is surprisingly correlated with the generation of a strong immunogenic response in both humans and animals.
    Type: Application
    Filed: August 13, 2020
    Publication date: November 10, 2022
    Applicant: Altimmune, Inc
    Inventors: Vyjayanthi Krishnan, M. Scot Roberts
  • Publication number: 20220331259
    Abstract: Therapeutic or prophylactic compositions providing an active agent, such as an antigen or a vector that contains and expresses an antigen, encapsulated in or incorporated into a biodegradable polymeric particle are provided. The compositions can also provide an active agent that is not encapsulated in or incorporated into the biodegradable polymeric particle in order to provide an initial or prime delivery of the active agent. Particles or composites providing an active agent encapsulated by a first and second polymer are also provided, wherein polymers are distributed in a gradient from a core of the composite to a surface of the composite, and configured to provide a delayed release of the active agent by a period of 7 days to 6 months. Methods of producing composites are also provided.
    Type: Application
    Filed: June 22, 2022
    Publication date: October 20, 2022
    Inventors: Allan E. David, Henry J. Baker, Aime K. Johnson, M. Scot Roberts, Kent R. Van Kampen, Prachi Sangle
  • Patent number: 11395802
    Abstract: Therapeutic or prophylactic compositions providing an active agent, such as an antigen or a vector that contains and expresses an antigen, encapsulated in or incorporated into a biodegradable polymeric particle are provided. The compositions can also provide an active agent that is not encapsulated in or incorporated into the biodegradable polymeric particle in order to provide an initial or prime delivery of the active agent. Particles or composites providing an active agent encapsulated by a first and second polymer are also provided, wherein polymers are distributed in a gradient from a core of the composite to a surface of the composite, and configured to provide a delayed release of the active agent by a period of 7 days to 6 months. Methods of producing composites are also provided.
    Type: Grant
    Filed: September 15, 2017
    Date of Patent: July 26, 2022
    Assignees: Auburn University, Altimmune, Inc.
    Inventors: Allan E. David, Henry J. Baker, Aime K. Johnson, M. Scot Roberts, Kent R. Van Kampen, Prachi Sangle
  • Patent number: 11382968
    Abstract: Provided in the present disclosure are immunogenic compounds, pharmaceutical formulations thereof and their use for inducing a protective immune response against 2019 novel coronavirus (SARS-CoV-2) infection and variants in a mammal.
    Type: Grant
    Filed: June 9, 2021
    Date of Patent: July 12, 2022
    Assignee: Altimmune Inc.
    Inventors: Bertrand Victor Gilbert Georges, M. Scot Roberts
  • Publication number: 20220072121
    Abstract: CORONAVIRUS IMMUNOGENIC COMPOSITIONS AND USES THEREOF Provided in the present disclosure are immunogenic compounds, pharmaceutical formulations thereof and their use for inducing a protective immune response against 2019 novel coronavirus (SARS-CoV-2) infection and variants in a mammal.
    Type: Application
    Filed: June 9, 2021
    Publication date: March 10, 2022
    Applicant: Altimmune, Inc
    Inventors: Bertrand Victor Gilbert Georges, M. Scot Roberts
  • Publication number: 20210260181
    Abstract: Provided in the present disclosure are immunogenic compounds, pharmaceutical formulations thereof and their use for inducing a protective immune response against 2019 novel coronavirus (SARS-CoV-2) infection and variants in a mammal.
    Type: Application
    Filed: February 12, 2021
    Publication date: August 26, 2021
    Applicant: Altimmune, Inc
    Inventors: Bertrand Victor Gilbert Georges, M. Scot Roberts
  • Publication number: 20210260180
    Abstract: Provided in the present disclosure are immunogenic compounds, pharmaceutical formulations thereof and their use for inducing a protective immune response against 2019 novel coronavirus (SARS-CoV-2) infection and variants in a mammal.
    Type: Application
    Filed: February 12, 2021
    Publication date: August 26, 2021
    Applicant: Altimmune, Inc
    Inventors: Bertrand Victor Gilbert Georges, M. Scot Roberts
  • Publication number: 20180078507
    Abstract: Therapeutic or prophylactic compositions providing an active agent, such as an antigen or a vector that contains and expresses an antigen, encapsulated in or incorporated into a biodegradable polymeric particle are provided. The compositions can also provide an active agent that is not encapsulated in or incorporated into the biodegradable polymeric particle in order to provide an initial or prime delivery of the active agent. Particles or composites providing an active agent encapsulated by a first and second polymer are also provided, wherein polymers are distributed in a gradient from a core of the composite to a surface of the composite, and configured to provide a delayed release of the active agent by a period of 7 days to 6 months. Methods of producing composites are also provided.
    Type: Application
    Filed: September 15, 2017
    Publication date: March 22, 2018
    Inventors: Allan E. David, Henry J. Baker, Aime K. Johnson, M. Scot Roberts, Kent R. Van Kampen, Prachi Sangle